(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are B.COM.PORTUGUES, AVANTIUM, and ASM INTERNATIONAL.

Financial Asset	Price	Change	Updated (EST)
B.COM.PORTUGUES (BCP.LS)	0.36	9.22%	2024-06-20 12:23:03
AVANTIUM (AVTX.AS)	2.56	6.44%	2024-06-20 12:00:41
ASM INTERNATIONAL (ASM.AS)	736.60	6.35%	2024-06-20 12:00:36
AKER HORIZONS (AKH.OL)	2.89	5.93%	2024-06-20 12:24:33
AB SCIENCE (AB.PA)	1.19	5.68%	2024-06-20 12:44:39
IBA (IBAB.BR)	14.06	5.56%	2024-06-20 12:20:13
V LANSCHOT KEMPEN (VLK.AS)	39.35	5.5%	2024-06-20 12:04:31
NYKODE THERAPEUTIC (NYKD.OL)	15.26	5.1%	2024-06-20 12:41:47
ENSURGE MICROPOWER (ENSU.OL)	1.52	4.95%	2024-06-20 12:26:04
ATOS (ATO.PA)	1.79	4.43%	2024-06-20 12:46:04

The three biggest losers today are TEKNA HOLDING, GRIEG SEAFOOD, and NORWEGIAN AIR SHUT.

Financial Asset	Price	Change	Updated (EST)
TEKNA HOLDING (TEKNA.OL)	4.86	-10.33%	2024-06-20 12:43:57
GRIEG SEAFOOD (GSF.OL)	66.35	-8.29%	2024-06-20 12:40:18
NORWEGIAN AIR SHUT (NAS.OL)	12.89	-7.83%	2024-06-20 12:41:41
NORTHERN OCEAN LTD (NOL.OL)	7.50	-6.95%	2024-06-20 12:41:39
VIVORYON (VVY.AS)	2.01	-6.29%	2024-06-20 12:04:42
NAPATECH (NAPA.OL)	35.00	-4.89%	2024-06-20 12:41:17
EUROCASTLE INVEST. (ECT.AS)	7.25	-4.61%	2024-06-20 12:01:56
GENTIAN DIAGNOSTIC (GENT.OL)	42.00	-4.11%	2024-06-20 12:40:09
BEVER HOLDING (BEVER.AS)	2.42	-3.97%	2024-06-20 12:00:57
NOVABASE,SGPS (NBA.LS)	5.20	-3.7%	2024-06-20 12:23:47

Winners today

1. B.COM.PORTUGUES (BCP.LS)

9.22% Price Change

Banco Comercial Português, S.A., a private sector bank, engages in the provision of various banking and financial products and services in Portugal and internationally. It operates through Retail Banking; Companies, Corporate & Investment Banking; Private Banking; Foreign Business; and Other segments. It offers a range of financial products and services, including current accounts, payment systems, savings and investment products, private banking, asset management, and investment banking services, such as mortgage loans, personal loans, commercial banking, leasing, factoring and insurance, and others. The company is also involved in the provision of investment fund and real estate management, e-commerce, web portal, real estate investment fund, trade finance, trust, consulting, brokerage, marketing, and real estate services, as well as internet, telephone, and mobile banking services. Banco Comercial Português, S.A. was incorporated in 1985 and is based in Porto, Portugal.

PSI ended the session with B.COM.PORTUGUES jumping 9.22% to €0.36 on Thursday, following the last session’s downward trend. PSI jumped 1.67% to €6,650.92, following the last session’s downward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, B.COM.PORTUGUES has a trailing twelve months EPS of €0.06.

PE Ratio

B.COM.PORTUGUES has a trailing twelve months price to earnings ratio of 5.98. Meaning, the purchaser of the share is investing €5.98 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.77%.

Volatility

B.COM.PORTUGUES’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.58%, a negative 0.51%, and a positive 1.68%.

B.COM.PORTUGUES’s highest amplitude of average volatility was 1.76% (last week), 1.47% (last month), and 1.68% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 14.1%, now sitting on 3.35B for the twelve trailing months.

Yearly Top and Bottom Value

B.COM.PORTUGUES’s stock is valued at €0.36 at 22:40 EST, under its 52-week high of €0.37 and way higher than its 52-week low of €0.20.

More news about B.COM.PORTUGUES.

2. AVANTIUM (AVTX.AS)

6.44% Price Change

Avantium N.V., a chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. The company operates through three segments: Avantium R&D Solutions, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It offers furandicarboxylic acid, a building block for polyethylene furanoate (PEF); and PEF, a plant-based recyclable plastic for use as packaging material. The company also provides catalyst testing systems, including Flowrence that provides catalyst testing and adsorbents. In addition, it offers R&D system and refinery catalyst testing services. Further, the company develops ray technology to produce mono-ethylene glycol from industrial sugars; and dawn technology which converts non-food plant-based feedstock to industrial sugars and lignin. Additionally, it produces polyesters using plantMEG. The company was founded in 2000 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with AVANTIUM jumping 6.44% to €2.56 on Thursday while AEX-Index jumped 0.98% to €933.84.

Earnings Per Share

As for profitability, AVANTIUM has a trailing twelve months EPS of €-0.7.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -46.5%.

Yearly Top and Bottom Value

AVANTIUM’s stock is valued at €2.56 at 22:40 EST, way below its 52-week high of €3.89 and way higher than its 52-week low of €2.00.

Revenue Growth

Year-on-year quarterly revenue growth grew by 13.1%, now sitting on 19.7M for the twelve trailing months.

Volatility

AVANTIUM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.70%, a negative 0.70%, and a positive 2.02%.

AVANTIUM’s highest amplitude of average volatility was 2.44% (last week), 1.94% (last month), and 2.02% (last quarter).

Volume

Today’s last reported volume for AVANTIUM is 487162 which is 15.76% above its average volume of 420836.

More news about AVANTIUM.

3. ASM INTERNATIONAL (ASM.AS)

6.35% Price Change

ASM International NV, together with its subsidiaries, engages in the research, development, manufacture, marketing, and servicing of equipment and materials used to produce semiconductor devices in Europe, the United States, and Asia. The company's products include wafer processing deposition systems for atomic layer deposition (ALD), epitaxy, silicon carbide, plasma enhanced chemical vapor deposition (PECVD), and vertical furnace systems, including low pressure chemical vapor deposition (LPCVD), diffusion, and oxidation products, as well as provides spare parts and support services. It also manufactures and sells equipment, which is used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. The company offers its products to semiconductor manufacturers. The company was formerly known as Advanced Semiconductor Materials International NV. ASM International NV was incorporated in 1968 and is headquartered in Almere, the Netherlands.

AEX-Index ended the session with ASM INTERNATIONAL rising 6.35% to €736.60 on Thursday, following the last session’s downward trend. AEX-Index rose 0.98% to €933.84, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, ASM INTERNATIONAL has a trailing twelve months EPS of €11.01.

PE Ratio

ASM INTERNATIONAL has a trailing twelve months price to earnings ratio of 66.9. Meaning, the purchaser of the share is investing €66.9 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.73%.

More news about ASM INTERNATIONAL.

4. AKER HORIZONS (AKH.OL)

5.93% Price Change

Aker Horizons ASA, through its subsidiaries, develops and invests in renewable energy and green technology private and public companies worldwide. The company offers modular and capture units for reducing and removing carbon dioxide emissions of various industries, including the cement, bio and waste-to-energy, gas-to-power and blue hydrogen segments. It also develops, owns, and operates industrial-scale hydrogen projects for industries, such as shipping, steel, and fertilizers; and operates onshore and offshore wind and solar power generation. The company was incorporated in 2020 and is based in Lysaker, Norway. Aker Horizons ASA operates as a subsidiary of Aker Capital ASA.

Oslo Børs Benchmark Index_GI ended the session with AKER HORIZONS jumping 5.93% to €2.89 on Thursday while Oslo Børs Benchmark Index_GI rose 0.36% to €1,409.34.

Earnings Per Share

As for profitability, AKER HORIZONS has a trailing twelve months EPS of kr-6.49.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.14%.

Yearly Top and Bottom Value

AKER HORIZONS’s stock is valued at kr2.89 at 22:40 EST, way below its 52-week low of kr5.12.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AKER HORIZONS’s stock is considered to be overbought (>=80).

More news about AKER HORIZONS.

5. AB SCIENCE (AB.PA)

5.68% Price Change

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

CAC 40 ended the session with AB SCIENCE jumping 5.68% to €1.19 on Thursday while CAC 40 jumped 1.34% to €7,671.34.

Earnings Per Share

As for profitability, AB SCIENCE has a trailing twelve months EPS of €-0.2.

Moving Average

AB SCIENCE’s value is way below its 50-day moving average of €3.07 and way below its 200-day moving average of €3.16.

Revenue Growth

Year-on-year quarterly revenue growth declined by 28.8%, now sitting on 777k for the twelve trailing months.

Yearly Top and Bottom Value

AB SCIENCE’s stock is valued at €1.19 at 22:40 EST, way below its 52-week low of €1.55.

More news about AB SCIENCE.

6. IBA (IBAB.BR)

5.56% Price Change

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

BEL 20 ended the session with IBA rising 5.56% to €14.06 on Thursday, following the last session’s downward trend. BEL 20 rose 0.72% to €3,889.35, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, IBA has a trailing twelve months EPS of €-0.31.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.2%.

Volume

Today’s last reported volume for IBA is 37073 which is 11.51% above its average volume of 33244.

Revenue Growth

Year-on-year quarterly revenue growth grew by 28.9%, now sitting on 428.72M for the twelve trailing months.

Volatility

IBA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.13%, a negative 0.50%, and a positive 1.85%.

IBA’s highest amplitude of average volatility was 3.05% (last week), 1.85% (last month), and 1.85% (last quarter).

Moving Average

IBA’s value is above its 50-day moving average of €13.71 and way higher than its 200-day moving average of €11.26.

More news about IBA.

7. V LANSCHOT KEMPEN (VLK.AS)

5.5% Price Change

Van Lanschot Kempen NV provides various financial services in the Netherlands and internationally. It operates through Private Clients, Wholesale and Institutional Clients, Investment Banking Clients, and Other segments. The company offers private banking services for entrepreneurs, family businesses, business professionals and executives, healthcare professionals, foundations, and associations. It provides online investment coach targets affluent individuals and millennials; and a range of investment strategies and fiduciary services to banks, wealth managers, family offices, pension funds, and insurers. In addition, the company offers specialist services, including equities research and trading, mergers and acquisitions services, capital market transactions, and debt advisory services to corporate and institutional investors. Further, it engages in the interest rate, market and liquidity risk management, and structured products activities. The company was formerly known as Van Lanschot Kempen Wealth Management NV and changed its name to Van Lanschot Kempen NV in July 2021. Van Lanschot Kempen NV was founded in 1737 and is headquartered in 's-Hertogenbosch, the Netherlands.

AEX-Index ended the session with V LANSCHOT KEMPEN jumping 5.5% to €39.35 on Thursday, following the last session’s downward trend. AEX-Index rose 0.98% to €933.84, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, V LANSCHOT KEMPEN has a trailing twelve months EPS of €2.78.

PE Ratio

V LANSCHOT KEMPEN has a trailing twelve months price to earnings ratio of 14.15. Meaning, the purchaser of the share is investing €14.15 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.17%.

More news about V LANSCHOT KEMPEN.

8. NYKODE THERAPEUTIC (NYKD.OL)

5.1% Price Change

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for T cell vaccine development; and research agreement with Regeneron. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NYKODE THERAPEUTIC jumping 5.1% to €15.26 on Thursday while Oslo Børs Benchmark Index_GI rose 0.36% to €1,409.34.

Earnings Per Share

As for profitability, NYKODE THERAPEUTIC has a trailing twelve months EPS of kr-1.39.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.89%.

Moving Average

NYKODE THERAPEUTIC’s worth is above its 50-day moving average of kr14.28 and way under its 200-day moving average of kr18.21.

Volume

Today’s last reported volume for NYKODE THERAPEUTIC is 1102580 which is 31.25% above its average volume of 840058.

Yearly Top and Bottom Value

NYKODE THERAPEUTIC’s stock is valued at kr15.26 at 22:40 EST, way under its 52-week high of kr30.50 and way above its 52-week low of kr12.38.

More news about NYKODE THERAPEUTIC.

9. ENSURGE MICROPOWER (ENSU.OL)

4.95% Price Change

Ensurge Micropower ASA provides energy storage solutions for wearable devices, connected sensors, and other applications in Norway. The company offers solid-state lithium battery technology that enables it to produce rechargeable batteries. It serves hearables, medical and sports/fitness wearables, and home and industrial devices sectors. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER rising 4.95% to €1.52 on Thursday while Oslo Børs Benchmark Index_GI rose 0.36% to €1,409.34.

Earnings Per Share

As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-3.36.

More news about ENSURGE MICROPOWER.

10. ATOS (ATO.PA)

4.43% Price Change

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, and telecommunication and media industries. The company was incorporated in 1982 and is headquartered in Bezons, France.

CAC 40 ended the session with ATOS jumping 4.43% to €1.79 on Thursday while CAC 40 jumped 1.34% to €7,671.34.

Earnings Per Share

As for profitability, ATOS has a trailing twelve months EPS of €-31.04.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATOS’s stock is considered to be oversold (<=20).

Volatility

ATOS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 23.26%, a negative 1.86%, and a positive 6.86%.

ATOS’s highest amplitude of average volatility was 23.26% (last week), 11.61% (last month), and 6.86% (last quarter).

More news about ATOS.

Losers Today

1. TEKNA HOLDING (TEKNA.OL)

-10.33% Price Change

Tekna Holding ASA engages in the development, manufacture, and sale of micron and nano powders, and plasma process solutions in North America, Europe, Asia, and internationally. The company offers spherical powders, such as titanium, nickel, and aluminum alloys, as well as tungsten and tantalum; and nanopowders, including nickel, silicon, and copper nanopowders, as well as boron nitride nanotubes for use in additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. It serves aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics industries. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.

Oslo Børs Benchmark Index_GI ended the session with TEKNA HOLDING dropping 10.33% to €4.86 on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.36% to €1,409.34, after three sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, TEKNA HOLDING has a trailing twelve months EPS of kr-1.01.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.02%.

Volume

Today’s last reported volume for TEKNA HOLDING is 1000 which is 97.82% below its average volume of 46078.

More news about TEKNA HOLDING.

2. GRIEG SEAFOOD (GSF.OL)

-8.29% Price Change

Grieg Seafood ASA, through its subsidiaries, operates as a fish farming company in Norway, the United Kingdom, rest of Europe, the United States, Canada, Asia, and internationally. It engages in the farming, production, and sale of Atlantic salmon. The company was incorporated in 1988 and is headquartered in Bergen, Norway. Grieg Seafood ASA is a subsidiary of Grieg Aqua AS.

Oslo Børs Benchmark Index_GI ended the session with GRIEG SEAFOOD falling 8.29% to €66.35 on Thursday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.36% to €1,409.34, after three successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, GRIEG SEAFOOD has a trailing twelve months EPS of kr-1.7.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.95%.

Sales Growth

GRIEG SEAFOOD’s sales growth is negative 20.8% for the present quarter and 41.9% for the next.

More news about GRIEG SEAFOOD.

3. NORWEGIAN AIR SHUT (NAS.OL)

-7.83% Price Change

Norwegian Air Shuttle ASA, together with its subsidiaries, provides air travel services in Norway and internationally. It is also involved in aircraft financing, leasing, and ownership activities; and cargo activities. It operates a fleet of 87 aircrafts. Norwegian Air Shuttle ASA was founded in 1993 and is headquartered in Fornebu, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORWEGIAN AIR SHUT falling 7.83% to €12.89 on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.36% to €1,409.34, after three sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, NORWEGIAN AIR SHUT has a trailing twelve months EPS of kr1.67.

PE Ratio

NORWEGIAN AIR SHUT has a trailing twelve months price to earnings ratio of 7.72. Meaning, the purchaser of the share is investing kr7.72 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.42%.

Volume

Today’s last reported volume for NORWEGIAN AIR SHUT is 24219700 which is 225.63% above its average volume of 7437680.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORWEGIAN AIR SHUT’s stock is considered to be oversold (<=20).

Moving Average

NORWEGIAN AIR SHUT’s worth is way under its 50-day moving average of kr15.24 and higher than its 200-day moving average of kr12.65.

Volatility

NORWEGIAN AIR SHUT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.27%, a negative 0.30%, and a positive 2.05%.

NORWEGIAN AIR SHUT’s highest amplitude of average volatility was 0.99% (last week), 2.00% (last month), and 2.05% (last quarter).

More news about NORWEGIAN AIR SHUT.

4. NORTHERN OCEAN LTD (NOL.OL)

-6.95% Price Change

Northern Ocean Ltd., a drilling contractor, provides offshore contract drilling services for the oil and gas industry worldwide. The company owns two semi-submersible rigs. It also invests in battery systems and power generation solutions. Northern Ocean Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN OCEAN LTD sliding 6.95% to €7.50 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.36% to €1,409.34.

Earnings Per Share

As for profitability, NORTHERN OCEAN LTD has a trailing twelve months EPS of kr-3.73.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.87%.

More news about NORTHERN OCEAN LTD.

5. VIVORYON (VVY.AS)

-6.29% Price Change

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.

AEX-Index ended the session with VIVORYON dropping 6.29% to €2.01 on Thursday while AEX-Index jumped 0.98% to €933.84.

Earnings Per Share

As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.

Volatility

VIVORYON’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.46%, a positive 4.68%, and a positive 7.98%.

VIVORYON’s highest amplitude of average volatility was 6.06% (last week), 13.20% (last month), and 7.98% (last quarter).

Volume

Today’s last reported volume for VIVORYON is 325857 which is 71.29% below its average volume of 1135050.

More news about VIVORYON.

6. NAPATECH (NAPA.OL)

-4.89% Price Change

Napatech A/S offers reconfigurable computing solutions for the networking and cybersecurity applications worldwide. The company provides Link Capture Software that enables packet capture with nanosecond timestamping and replay with precise inter-frame gap control; Link Inline Software, which offers a processing architecture that offloads and accelerates flow aware application data planes; Link Virtualization Software that offloads and accelerates the Open vSwitch data plane to enhance CPU efficiency and network performance; and Link Programmable, which enables end users and OEMs to deploy FPGA computation solutions. It offers solutions for telecom operators, cloud and data center service providers, and infrastructure and defense, as well as financial services, cyber security, network management, and virtualization. Napatech A/S was incorporated in 2003 and is based in Copenhagen, Denmark.

Oslo Børs Benchmark Index_GI ended the session with NAPATECH dropping 4.89% to €35.00 on Thursday while Oslo Børs Benchmark Index_GI rose 0.36% to €1,409.34.

Earnings Per Share

As for profitability, NAPATECH has a trailing twelve months EPS of kr-0.7.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.66%.

Yearly Top and Bottom Value

NAPATECH’s stock is valued at kr35.00 at 22:40 EST, below its 52-week high of kr38.60 and way above its 52-week low of kr8.70.

Volatility

NAPATECH’s last week, last month’s, and last quarter’s current intraday variation average was 0.90%, 0.07%, and 4.53%.

NAPATECH’s highest amplitude of average volatility was 3.32% (last week), 3.04% (last month), and 4.53% (last quarter).

Volume

Today’s last reported volume for NAPATECH is 132685 which is 64.44% below its average volume of 373172.

More news about NAPATECH.

7. EUROCASTLE INVEST. (ECT.AS)

-4.61% Price Change

Eurocastle Investment Limited is a publicly traded closed-ended investment company that focuses on investing in performing and nonperforming loans and other real estate related assets primarily in Italy. The Company is Euro denominated and is listed on Euronext Amsterdam under the symbol “ECT”. Eurocastle is managed by an affiliate of Fortress Investment Group LLC, a leading global investment manager. For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com.

AEX-Index ended the session with EUROCASTLE INVEST. dropping 4.61% to €7.25 on Thursday, following the last session’s upward trend. AEX-Index rose 0.98% to €933.84, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, EUROCASTLE INVEST. has a trailing twelve months EPS of €-0.64.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.88%.

Sales Growth

EUROCASTLE INVEST.’s sales growth is negative 113.8% for the current quarter and negative 113.8% for the next.

Yearly Top and Bottom Value

EUROCASTLE INVEST.’s stock is valued at €7.25 at 22:40 EST, way below its 52-week high of €11.14 and way higher than its 52-week low of €6.00.

Volatility

EUROCASTLE INVEST.’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.40%, a negative 0.53%, and a positive 2.58%.

EUROCASTLE INVEST.’s highest amplitude of average volatility was 3.40% (last week), 2.44% (last month), and 2.58% (last quarter).

Moving Average

EUROCASTLE INVEST.’s value is below its 50-day moving average of €7.51 and under its 200-day moving average of €7.64.

More news about EUROCASTLE INVEST..

8. GENTIAN DIAGNOSTIC (GENT.OL)

-4.11% Price Change

Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research worldwide. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric immunoassay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a glomerular filtration rate marker for the diagnosis and therapeutic control of renal function; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and canine CRP immunoassay test kit, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine C-reactive protein in dog plasma and serum. It also provides SARS-CoV-2 total antibody immunoassay, quantitative antibody test captures the full immune response detecting antibodies targeting the S1-subunit. In addition, the company develops NT-proBNP Immunoassay, an aid in the diagnosis, monitoring and assessment of severity in individuals suspected of having congestive heart failure which is in product development phase. Further, it offers faecal calprotectin immunoassay, provides results of calprotectin in stool supporting diagnosis of inflammatory bowel disease; and faecal pancreatic elastase immunoassay which allows analysis of pancreatic elastase in stool to aid in diagnosis of pancreatic exocrine insufficiency. The company was founded in 2001 and is headquartered in Moss, Norway.

Oslo Børs Benchmark Index_GI ended the session with GENTIAN DIAGNOSTIC falling 4.11% to €42.00 on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.36% to €1,409.34, after three successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, GENTIAN DIAGNOSTIC has a trailing twelve months EPS of kr-0.38.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.82%.

More news about GENTIAN DIAGNOSTIC.

9. BEVER HOLDING (BEVER.AS)

-3.97% Price Change

Bever Holding NV operates as a real estate company in the Netherlands and Belgium. The company develops residential and non-residential properties. It also invests in, acquires, and leases real estate properties. The company was incorporated in 1975 and is based in Wassenaar, the Netherlands.

AEX-Index ended the session with BEVER HOLDING falling 3.97% to €2.42 on Thursday, after five sequential sessions in a row of losses. AEX-Index jumped 0.98% to €933.84, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, BEVER HOLDING has a trailing twelve months EPS of €-0.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.54%.

Moving Average

BEVER HOLDING’s value is under its 50-day moving average of €2.46 and below its 200-day moving average of €2.58.

More news about BEVER HOLDING.

10. NOVABASE,SGPS (NBA.LS)

-3.7% Price Change

Novabase S.G.P.S., S.A., through its subsidiaries, provides IT consulting and services in Portugal, rest of Europe, Africa, the Middle East, and internationally. It operates through two segments, Next-Gen and Value Portfolio. The Next-Gen segment develops IT consulting and services to banks, insurance, capital markets, and telecommunication industries under the Celfocus brand name. The Value Portfolio segment is involved in venture capital activities. Novabase S.G.P.S., S.A. was incorporated in 1989 and is headquartered in Lisbon, Portugal.

PSI ended the session with NOVABASE,SGPS sliding 3.7% to €5.20 on Thursday while PSI rose 1.67% to €6,650.92.

Earnings Per Share

As for profitability, NOVABASE,SGPS has a trailing twelve months EPS of €0.11.

PE Ratio

NOVABASE,SGPS has a trailing twelve months price to earnings ratio of 47.27. Meaning, the purchaser of the share is investing €47.27 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.03%.

More news about NOVABASE,SGPS.

Stay up to date with our winners and losers daily report